At Metametrix, we continue to develop innovative testing profiles with “Next Generation Technology” to further advance treatment options for chronic diseases such as cardiovascular, gastrointestinal, inflammatory, mental/emotional, and autism spectrum disorders. We currently have five patents pending for new methods and applications with more in the pipeline.

As an early adopter of advances in laboratory science, Metametrix functions as a reference provider for other clinical laboratories wanting to offer our innovative services to their clients. The company also performs testing for research institutions as they study the influence of nutrients and toxicities on health.